EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY-NC 4.0

DNA methylation profiling of myelodysplastic syndromes and clinical response to azacitidine: A multicentre retrospective study

Aleix Noguera-Castells iD, Ignacio Campillo-Marcos iD, Veronica Davalos iD, Carlos A García-Prieto iD, David Valcárcel iD, Antonieta Molero iD, Laura Palomo iD, Norbert Gattermann, Michael Wulfert, Lorea Chaparro-González iD, Francesc Solé iD, Marta Cabezón und 8 weitere

British Journal of Haematology · 2024

DOI: 10.1111/bjh.19392 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift British Journal of Haematology, 2024. Verfasst von Aleix Noguera-Castells und 19 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Epigenetics Group, Josep Carreras Leukaemia Research Institute (IJC), Barcelona, Catalonia, Spain. Hauptthemen laut MEDLINE: Azacitidine, Myelodysplastic Syndromes, DNA Methylation. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: European Regional Development Fund, Departament de Recerca i Universitats/Generalitat de Catalunya, Fundación Cellex.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Real‐world data have revealed that a substantial portion of patients with myelodysplastic syndromes (MDS) does not respond to epigenetic therapy with hypomethylating agents (HMAs). The cellular and molecular reasons for this resistance to the demethylating agent and biomarkers that would be able to predict the treatment refractoriness are largely unknown. In this study, we shed light on this enigma by characterizing the epigenomic profiles of patients with MDS treated with azacitidine. Our approach provides a comprehensive view of the evolving DNA methylation architecture of the disease and holds great potential for advancing our understanding of MDS treatment responses to HMAs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AzacitidineMyelodysplastic SyndromesDNA MethylationHumansRetrospective StudiesMaleFemaleAgedMiddle AgedAntimetabolites, AntineoplasticAged, 80 and overEpigenesis, GeneticTreatment Outcome

Stichwörter der Autor:innen

DNA methylationazacitidinehypomethylating agentsmyelodysplastic syndromes

Substanzen

AzacitidineAntimetabolites, Antineoplastic

Autor:innen und Institutionen

  • Cancer Epigenetics Group, Josep Carreras Leukaemia Research Institute (IJC), Barcelona, Catalonia, Spain.
  • Department of Biosciences, Faculty of Science, Technology and Engineering, University of Vic - Central University of Catalonia (UVic-UCC), Vic, Barcelona, Catalonia, Spain.
  • Centro de Investigacion Biomedica en Red Cancer (CIBERONC), Madrid, Spain.
  • Life Sciences Department, Barcelona Supercomputing Center (BSC), Barcelona, Catalonia, Spain.
  • Department of Hematology, Experimental Hematology Unit, Vall d'Hebron Institute of Oncology (VHIO), University Hospital Vall d'Hebron, Barcelona, Spain.
  • Department of Hematology, Oncology and Clinical Immunology, University Cancer Center, Universitätsklinikum Düsseldorf, Düsseldorf, Germany.

ORCID-Profile: Aleix Noguera-Castells, Ignacio Campillo-Marcos, Veronica Davalos, Carlos A García-Prieto, David Valcárcel, Antonieta Molero, Laura Palomo, Lorea Chaparro-González, Francesc Solé, Blanca Xicoy, Lurdes Zamora, Manel Esteller

Förderung

  • European Regional Development Fund
  • Departament de Recerca i Universitats/Generalitat de Catalunya
  • Fundación Cellex
  • Generalitat de Catalunya

Zitieren

APA

Noguera-Castells, A., Campillo-Marcos, I., Davalos, V., García-Prieto, C. A., Valcárcel, D., Molero, A., Palomo, L., Gattermann, N., Wulfert, M., Chaparro-González, L., Solé, F., Cabezón, M., Jiménez-Lorenzo, M. J., Xicoy, B., Zamora, L., De Stefano, A., Casalin, I., Finelli, C., Follo, M. Y., & Esteller, M. (2024). DNA methylation profiling of myelodysplastic syndromes and clinical response to azacitidine: A multicentre retrospective study. British Journal of Haematology. https://doi.org/10.1111/bjh.19392

Vancouver

Noguera-Castells A, Campillo-Marcos I, Davalos V, García-Prieto CA, Valcárcel D, Molero A, et al. DNA methylation profiling of myelodysplastic syndromes and clinical response to azacitidine: A multicentre retrospective study. British Journal of Haematology. 2024. doi:10.1111/bjh.19392

BibTeX
@article{NogueraCastells2024,
  author = {Noguera-Castells, Aleix and Campillo-Marcos, Ignacio and Davalos, Veronica and García-Prieto, Carlos A and Valcárcel, David and Molero, Antonieta and Palomo, Laura and Gattermann, Norbert and Wulfert, Michael and Chaparro-González, Lorea and Solé, Francesc and Cabezón, Marta and Jiménez-Lorenzo, María J and Xicoy, Blanca and Zamora, Lurdes and De Stefano, Alessia and Casalin, Irene and Finelli, Carlo and Follo, Matilde Y and Esteller, Manel},
  title = {DNA methylation profiling of myelodysplastic syndromes and clinical response to azacitidine: A multicentre retrospective study},
  journal = {British Journal of Haematology},
  year = {2024},
  doi = {10.1111/bjh.19392}
}
Kostenlos starten →